0
When the replaced genes functions properly and corrects the defect in that region a gene therapy is successful and the desired result is achieved.
Wiki User
∙ 11y ago
Add your answer:
Earn +20 pts
What is the desired outcome of gene therapy?
Gene therapy has the desired outcome of eradicating or curing diseases that are caused by a specific abnormality or mutation of a gene that is a killer. It is a developing science and slowly getting results.
Which drug is manufactured as a result of indirect gene therapy?
Human insulin
Inserting working copies of a gene directly into the cells of a person with a genetic disorder is called what?
Gene TherapyGenetic disorders are caused by an abnormality in person's DNA.
Why do you need gene therapy?
gene therapy is when a faulty gene is repaired or replaced
How do gene splicing and gene therapy difffer?
Gene therapy usually seeks to replace a defective gene in a cell with the correct one using a vector for delivery, often a virus. The result is the transformed cells will product the correct protein. Protein therapy usually refers to injecting a functional protein into a patient to compensate for its absence.
Difference between gene therapy and protein therapy?
at the gene level gene therapy is done and at the the protein level protein therapy is done
A technique that involves putting a healthy copy of a gene into cells that have a defective copy of the same gene?
gene therapy.
How could gene therapy be used to treat cancer?
With the help of Gene therapy we can replace or supress the cancer gene
What 'tools' are used in gene therapy?
Viral vectors are the tools used in gene therapy.
When was gene therapy on allowed?
in 1989 us approve gene therapy exprement on human
How does gene therapy effect children?
Gene therapy effects children by helping to cure disease and to lengthen lives. Gene therapy can also be used to eliminate diseases that are inherited.
What conditions can not be treated by gene therapy?
Many of the more commonly occurring disorders, including heart disease, diabetes, and high blood pressure, result from defects in multiple genes making them unlikely candidates for gene therapy using existing technologies.
